Endothelium-Driven Myocardial Growth or Nitric Oxide at the Crossroads

Trends in Cardiovascular Medicine

Volumn 18, Issue 8, 2008, Pages 299-305

  Tirziu, Daniela ^a   Simons, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANGIOGENESIS; CELL COMMUNICATION; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD COAGULATION FACTORS; CARDIOMEGALY; CORONARY CIRCULATION; ENDOTHELINS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTORS; HUMANS; ION CHANNEL GATING; MYOCARDIUM; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; PARACRINE COMMUNICATION; PLATELET-DERIVED GROWTH FACTOR; PROSTAGLANDINS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 63249131125     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2009.01.002     Document Type: Review

References (66)

1. Amano K., Matsubara H., Iba O., et al. Enhancement of ischemia-induced angiogenesis by eNOS overexpression. Hypertension 41 (2003) 156-162
2. Andries L.J., Brutsaert D.L., and Sys S.U. Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circ Res 82 (1998) 195-203
3. Barouch L.A., Harrison R.W., Skaf M.W., et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416 (2002) 337-339
4. Cheng T.H., Shih N.L., Chen S.Y., et al. Nitric oxide inhibits endothelin-1-induced cardiomyocyte hypertrophy through cGMP-mediated suppression of extracellular-signal regulated kinase phosphorylation. Mol Pharmacol 68 (2005) 1183-1192
5. Dorn II G.W., Robbins J., and Sugden P.H. Phenotyping hypertrophy: eschew obfuscation. Circ Res 92 (2003) 1171-1175
6. Feron O., and Balligand J.L. Caveolins and the regulation of endothelial nitric oxide synthase in the heart. Cardiovasc Res 69 (2006) 788-797
7. Fiedler B., Lohmann S.M., Smolenski A., et al. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc Natl Acad Sci U S A 99 (2002) 11363-11368
8. Fiedler B., and Wollert K.C. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes. Cardiovasc Res 63 (2004) 450-457
9. Fransen P., Hendrickx J., Brutsaert D.L., and Sys S.U. Distribution and role of Na(+)/K(+) ATPase in endocardial endothelium. Cardiovasc Res 52 (2001) 487-499
10. Fransen P., Hendrickx J., and De Keulenaer G. The endocardial endothelial Na+/K+ ATPase and cardiac contraction. Adv Exp Med Biol 538 (2003) 43-56 discussion 56
11. Gratton J.P., Bernatchez P., and Sessa W.C. Caveolae and caveolins in the cardiovascular system. Circ Res 94 (2004) 1408-1417
12. Gyurko R., Kuhlencordt P., Fishman M.C., and Huang P.L. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol Heart Circ Physiol 278 (2000) H971-H981
13. Hariawala M.D., Horowitz J.R., Esakof D., et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 63 (1996) 77-82
14. Heineke J., Auger-Messier M., Xu J., et al. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest 117 (2007) 3198-3210
15. Heineke J., Kempf T., Kraft T., et al. Downregulation of cytoskeletal muscle LIM protein by nitric oxide: impact on cardiac myocyte hypertrophy. Circulation 107 (2003) 1424-1432
16. Hendel R.C., Henry T.D., Rocha-Singh K., et al. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation 101 (2000) 118-121
17. Henry T.D., Rocha-Singh K., Isner J.M., et al. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J 142 (2001) 872-880
18. Hood J.D., Meininger C.J., Ziche M., and Granger H.J. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 274 (1998) H1054-H1058
19. Horowitz J.R., Rivard A., Van der Zee R., et al. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. Arterioscler Thromb Vasc Biol 17 (1997) 2793-2800
20. Hu R.G., Sheng J., Qi X., et al. The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators. Nature 437 (2005) 981-986
21. Hubbard K.B., and Hepler J.R. Cell signalling diversity of the Gqalpha family of heterotrimeric G proteins. Cell Signal 18 (2006) 135-150
22. Ichinose F., Bloch K.D., Wu J.C., et al. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. Am J Physiol Heart Circ Physiol 286 (2004) H1070-H1075
23. Izumiya Y., Shiojima I., Sato K., et al. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 47 (2006) 887-893
24. Jones S.P., Greer J.J., Van Haperen R., et al. Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci U S A 100 (2003) 4891-4896
25. Kureishi Y., Luo Z., Shiojima I., et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6 (2000) 1004-1010
26. Kuruvilla L., and Kartha C.C. Molecular mechanisms in endothelial regulation of cardiac function. Mol Cell Biochem 253 (2003) 113-123
27. Layland J., Li J.M., and Shah A.M. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol 540 (2002) 457-467
28. Lee M.J., Tasaki T., Moroi K., et al. RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. Proc Natl Acad Sci U S A 102 (2005) 15030-15035
29. Lopez J.J., Laham R.J., Carrozza J.P., et al. Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response. Am J Physiol 273 (1997) H1317-H1323
30. Martin S.R., Emanuel K., Sears C.E., et al. Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation. Cardiovasc Res 70 (2006) 97-106
31. Massion P.B., Feron O., Dessy C., and Balligand J.L. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93 (2003) 388-398
32. Massion P.B., Pelat M., Belge C., and Balligand J.L. Regulation of the mammalian heart function by nitric oxide. Comp Biochem Physiol A Mol Integr Physiol 142 (2005) 144-150
33. Mees B., Wagner S., Ninci E., et al. Endothelial nitric oxide synthase activity is essential for vasodilation during blood flow recovery but not for arteriogenesis. Arterioscler Thromb Vasc Biol 27 (2007) 1926-1933
34. Mittmann C., Chung C.H., Hoppner G., et al. Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure. Cardiovasc Res 55 (2002) 778-786
35. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109-142
36. Oshima Y., Ouchi N., Sato K., et al. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation 117 (2008) 3099-3108
37. Ouchi N., Oshima Y., Ohashi K., et al. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric oxide synthesis-dependent mechanism. J Biol Chem (2008)
38. Ozaki M., Kawashima S., Yamashita T., et al. Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. Circ J 66 (2002) 851-856
39. Paulus W.J. The role of nitric oxide in the failing heart. Heart Fail Rev 6 (2001) 105-118
40. Paulus W.J., Vantrimpont P.J., and Shah A.M. Paracrine coronary endothelial control of left ventricular function in humans. Circulation 92 (1995) 2119-2126
41. Pisconti A., Brunelli S., Di Padova M., et al. Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion. J Cell Biol 172 (2006) 233-244
42. Rogers J.H., Tamirisa P., Kovacs A., et al. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J Clin Invest 104 (1999) 567-576
43. Rogers J.H., Tsirka A., Kovacs A., et al. RGS4 reduces contractile dysfunction and hypertrophic gene induction in Galpha q overexpressing mice. J Mol Cell Cardiol 33 (2001) 209-218
44. Ruiz-Hurtado G., Fernandez-Velasco M., Mourelle M., and Delgado C. LA419, a novel nitric oxide donor, prevents pathological cardiac remodeling in pressure-overloaded rats via endothelial nitric oxide synthase pathway regulation. Hypertension 50 (2007) 1049-1056
45. Scherrer-Crosbie M., Ullrich R., Bloch K.D., et al. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 104 (2001) 1286-1291
46. Seddon M., Shah A.M., and Casadei B. Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc Res 75 (2007) 315-326
47. Shah A.M., Grocott-Mason R.M., Pepper C.B., et al. The cardiac endothelium: cardioactive mediators. Prog Cardiovasc Dis 39 (1996) 263-284
48. Shah A.M., and MacCarthy P.A. Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther 86 (2000) 49-86
49. Shah A.M., Spurgeon H.A., Sollott S.J., et al. 8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ Res 74 (1994) 970-978
50. Shiojima I., Sato K., Izumiya Y., et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115 (2005) 2108-2118
51. Shiojima I., Yefremashvili M., Luo Z., et al. Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J Biol Chem 277 (2002) 37670-37677
52. Simons M. Molecular multitasking: statins lead to more arteries, less plaque. Nat Med 6 (2000) 965-966
53. Smith Jr. R.S., Agata J., Xia C.F., et al. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci 76 (2005) 2457-2471
54. Stamler J.S., Singel D.J., and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 258 (1992) 1898-1902
55. Takimoto E., Champion H.C., Li M., et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 115 (2005) 1221-1231
56. Tamirisa P., Blumer K.J., and Muslin A.J. RGS4 inhibits G-protein signaling in cardiomyocytes. Circulation 99 (1999) 441-447
57. Tirziu D., Chorianopoulos E., Moodie K.L., et al. Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice. J Clin Invest 117 (2007) 3188-3197
58. Tirziu D., and Simons M. Endothelium as master regulator of organ development and growth. Vascul Pharmacol 50 (2009) 1-7
59. Van Deel E.D., Merkus D., Van Haperen R., et al. Vasomotor control in mice overexpressing human endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 293 (2007) H1144-H1153
60. Vila-Petroff M.G., Younes A., Egan J., et al. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 84 (1999) 1020-1031
61. Walsh K., and Shiojima I. Cardiac growth and angiogenesis coordinated by intertissue interactions. J Clin Invest 117 (2007) 3176-3179
62. Wieland T., and Mittmann C. Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system. Pharmacol Ther 97 (2003) 95-115
63. Williams J.C., Armesilla A.L., Mohamed T.M., et al. The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex. J Biol Chem 281 (2006) 23341-23348
64. Xu K.Y., Huso D.L., Dawson T.M., et al. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 96 (1999) 657-662
65. Yamashita T., Kawashima S., Ohashi Y., et al. Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. Hypertension 36 (2000) 97-102
66. Yu J., deMuinck E.D., Zhuang Z., et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci U S A 102 (2005) 10999-11004